Paper Details

  1. Home
  2. Paper Details

T4 but not T3 administration is associated with increased recurrence of Graves' disease after successful medical therapy.

Author: DoufasA G, KoutrasD A, MantzosE, MantzosJ, MastorakosG

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

The study found that T4 administration after successful antithyroid drug (ATD) treatment of Graves' disease is associated with increased recurrence of hyperthyroidism compared to T3 or placebo administration.
Paper Details　
Original Abstract of the Article :
TSH has been incriminated in Graves' disease for increasing the production of antibodies against TSH receptor (TRAb). It has been, therefore, suggested that T4 administration after successful antithyroid drug (ATD) treatment may indirectly decrease the production of TRAb and, therefore, the frequenc...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/BF03348195

データ提供：米国国立医学図書館（NLM）

The Role of T4 and T3 in Graves' Disease Recurrence: A Tale of Two Hormones

Graves' disease, an autoimmune disorder affecting the thyroid, often requires treatment with antithyroid drugs (ATD). This study examines the role of different thyroid hormone replacement therapies, T4 and T3, in the recurrence of Graves' disease after successful ATD treatment. The researchers followed patients for two years after successful treatment, randomly assigning them to receive either T4, T3, or placebo. They found that T4 administration was associated with a higher recurrence rate of hyperthyroidism compared to T3 or placebo. This study suggests that the choice of thyroid hormone replacement therapy may have a significant impact on the likelihood of Graves' disease recurrence, underscoring the importance of careful consideration in treatment decisions.

T4 or T3: Navigating the Shifting Sands of Thyroid Hormone Replacement

This research suggests that T4 administration after successful treatment of Graves' disease with ATD may be associated with a higher recurrence rate compared to T3 or placebo. This finding highlights the importance of carefully selecting the appropriate thyroid hormone replacement therapy to minimize the risk of recurrence and ensure optimal long-term management of Graves' disease.

Finding the Right Path: Optimizing Treatment for Graves' Disease

This research offers valuable insights into the management of Graves' disease. The findings suggest that the choice of thyroid hormone replacement therapy may play a significant role in preventing recurrence. This information is essential for healthcare professionals in making informed treatment decisions, ensuring the best possible outcomes for patients with Graves' disease.

Dr.Camel's Conclusion

This research highlights the importance of considering the specific needs of individual patients when selecting thyroid hormone replacement therapy after successful treatment of Graves' disease. The study suggests that T3 may be a more effective option for reducing the risk of recurrence compared to T4.

Date :
  1. Date Completed 2004-09-07
  2. Date Revised 2019-10-26
Further Info :

Pubmed ID

14759070

DOI: Digital Object Identifier

10.1007/BF03348195

Related Literature

Article Analysis
・Effective treatment of hyperthyroidism
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.